Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

107 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Twilio Announces Retirement of Byron Deeter and Board Declassification
BU
Twilio Appoints Andy Stafman to Board of Directors
BU
Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComa
PR
Emerson Honors 99 St. Louis Area Educators with Excellence in Teaching Awards
AQ
Transcript : Cogent Biosciences, Inc. - Special Call
Cogent Biosciences Announces Positive Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST)
AQ
Cogent Biosciences to Host Investor Webcast to Discuss Lead-In Data Being Presented at ASCO from the Ongoing Phase 3 PEAK Trial in Patients with Gastrointestinal Stromal Tumors (GIST)
AQ
Ginkgo Bioworks Previews Today's Annual Ferment Conference
PR
FOX News Channel Finishes First Quarter of 2023 as Top Network in All of Cable With Viewers Across Primetime and Total Day
BU
TWILIO INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
Scotiabank hosts second annual employee Allyship Summit to support a diverse and inclusive workplace
AQ
FOX News Channel Scores Seventh Consecutive Year as Leader in All of Cable Television
BU
Transcript : Abercrombie & Fitch Co., Q3 2023 Earnings Call, Nov 22, 2022
COGENT BIOSCIENCES REPORTS RECENT BUSINESS HIGHLIGHTS AND THIRD QUARTER 2022 FINANCIAL RESULTS
AQ
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2022 Financial Results
AQ
FOX News Channel Dominates Third Quarter of 2022 and Remains Cable’s Highest-Rated Network in Primetime and Total Day Viewers
BU
FOX News Channel Finishes August as Third Highest-Rated Network in All of Television
BU
Transcript : Swiss Steel Holding AG, Q2 2022 Earnings Call, Aug 16, 2022
Transcript : B2Gold Corp. - Shareholder/Analyst Call
Twilio Welcomes New Executives: Reeny Sondhi as Company's First Chief Digital Officer and Amy Holcroft as Company's First Chief Privacy Officer
AQ
Twilio Inc. Hires Reeny Sondhi as Chief Digital Officer and Amy Holcroft as Chief Privacy Officer
CI
Twilio Welcomes New Executives: Reeny Sondhi as Company’s First Chief Digital Officer and Amy Holcroft as Company’s First Chief Privacy Officer
PU
National Research : 2021 Annual Report/ Proxy Statement
PU
AAON : Annual Report (Form ARS)
PU
Scotiabank commits over $1 million in Ukrainian aid to support humanitarian and resettlement efforts
AQ
Twilio : Announces Fourth Quarter and Full Year 2021 Results - Form 8-K
PU
Twilio Announces Fourth Quarter and Full Year 2021 Results
BU
Twilio : Initial Statement of Beneficial Ownership (Form 3)
PU
Aadi Bioscience : Announces FDA Approval of its First Product FYARRO™ for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa) - Form 8-K
PU
Aadi Bioscience Announces FDA Approval of its First Product FYARRO™ for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa)
GL
Aadi Bioscience Announces FDA Approval of its First Product FYARRO™ for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa)
GL
Aadi Bioscience Presents Two Abstracts on FYARRO (nab-Sirolimus) at the Annual Meeting of the Connective Tissue Oncology Society (CTOS)
AQ
Immunitas Therapeutics Names Amanda Wagner as CEO
PR
UPDATE – Aadi Bioscience Presents Two Abstracts on FYARRO (nab-Sirolimus) at the Annual Meeting of the Connective Tissue Oncology Society (CTOS)
GL
Aadi Bioscience Presents Two Abstracts on FYARRO (nab-Sirolimus) at the Annual Meeting of the Connective Tissue Oncology Society (CTOS)
AQ
Aadi Bioscience Presents Two Abstracts on FYARRO (nab-Sirolimus) at the Annual Meeting of the Connective Tissue Oncology Society
CI
Twilio Welcomes Eyal Manor as Chief Product Officer and Dana Wagner as Chief Legal Officer
BU
Twilio Announces Executive Changes
CI
Aadi Bioscience : Announces Publication of its Phase 2 Registrational (AMPECT) Trial of nab-Sirolimus in Patients with Malignant Perivascular Epithelioid Cell Tumors in the Journal of Clinical Oncology
AQ
Dana Incorporated cancelled the acquisition of Liquid Cooled Portion of Automotive Business of Modine Manufacturing Company.
CI
Aadi Bioscience : Announces Publication of its Phase 2 Registrational (AMPECT) Trial of nab-Sirolimus in Patients with Malignant Perivascular Epithelioid Cell Tumors in the Journal of Clinical Oncology
AQ
Immunitas Therapeutics Appoints Seng-Lai 'Thomas' Tan, Ph.D. as Chief Scientific Officer
PR
KKR : Supports 100 Small Businesses and Nonprofits in Latest Grants to Aid Global Economic Recovery
BU
Grant Thornton announces a record 87 new partners, principals and managing directors
BU
Dana Incorporated completed the acquisition of Liquid Cooled Portion of Automotive Business of Modine Manufacturing Company from Modine Manufacturing Company.
CI
Dana Incorporated entered into a definitive agreement to acquire Liquid Cooled Portion of Automotive Business of Modine Manufacturing Company for $1.
CI
Envestnet : Welcomes WealthTech Veteran Dani Fava as Head of Strategic Development
PR
U.S. Department of Commerce Invests $5.2 Million in CARES Act Funding to Capitalize Revolving Loan Funds to Help Small Businesses Across Missouri Respond to Coronavirus
PU
Impossible Foods : Wins Injunction in EU Trademark Infringement Case
BU
Immunitas Therapeutics : Launches with $39 Million to Advance Lead Programs to Human Efficacy Studies Based on a Unique Immunology-Focused Drug Development Platform
BU
No results for this search
  1. Stock Market
  2. Advanced search
  3. Dana Wagner
  4. News